CHI3L1 and liver cancer: To assess the in vivo metastatic potential of CHI3L1 overexpression or knockdown in liver cancer cells, we injected the HepG2-shCHI3L1, Bel7404-CHI3L1 and their control cells into the tail veins of nude mice.